STERIS (STE) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

STERIS (STE)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

207.46

0.09 (0.04%)

At close: Jan 14, 2025, 3:59 PM

207.57

0.05%

After-hours Jan 14, 2025, 04:10 PM EST

undefined% (undefined)

Bid	84.2
Market Cap	20.48B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	5.95
PE Ratio (ttm)	34.87
Forward PE	n/a
Analyst	Buy

Ask	260
Volume	366,465
Avg. Volume (20D)	589,691
Open	208.03
Previous Close	207.37
Day's Range	205.42 - 208.03
52-Week Range	197.82 - 248.24
Beta	undefined

About STE

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capit...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jun 1, 1992

Employees 18,000

Stock Exchange NYSE

Ticker Symbol STE

Website https://www.steris.com

Analyst Forecast

According to 5 analyst ratings, the average rating for STE stock is "Buy." The 12-month stock price forecast is $262.5, which is an increase of 26.53% from the latest price.

Buy 80.00%

Hold 20.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

STERIS is scheduled to release its earnings on Feb 5, 2025, during market hours.
Analysts project revenue of $1.38B, reflecting a -1.15% YoY shrinking and earnings per share of 2.34, making a 5.41% increase YoY.

Why Price Moved

2 months ago · Source

-5.28%

Steris shares are trading lower after the company ... Unlock content with Pro Subscription

2 months ago · Source

+2.75%

STERIS shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $230 to $260.

News

2 weeks ago · zacks.com

STERIS Gains From Expanded Product Offerings Amid Macro Issues

STE expects bioprocessing revenues to grow in the second half of fiscal 2025.

4 weeks ago · zacks.com

Reasons to Retain STE Stock in Your Portfolio Now

STERIS' strong prospects in the healthcare business bode well for investors.

1 month ago · zacks.com

Why Is Steris (STE) Up 0.9% Since Last Earnings Report?

Steris (STE) reported earnings 30 days ago. What's next for the stock?

1 month ago · zacks.com

New Alliances to Support STERIS Stock Despite Macro Issues

STE expects bioprocessing revenues to grow in the second half of fiscal 2025.

1 month ago · seekingalpha.com

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

I am upgrading STERIS to a 'Buy' with a fair value of $240 per share due to the recent stock price pullback and solid growth prospects. STERIS reported 7.2% organic revenue growth and 5.4% adjusted EP...

2 months ago · zacks.com

Why Steris (STE) International Revenue Trends Deserve Your Attention

Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

2 months ago · zacks.com

STE Q2 Earnings Beat Estimates, Margins Dip, Stock Gains in Aftermarket

STERIS' second-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. The contraction of both margins is concerning.

2 months ago · zacks.com

Compared to Estimates, Steris (STE) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stree...

2 months ago · zacks.com

Steris (STE) Surpasses Q2 Earnings Estimates

Steris (STE) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2.11 per share. This compares to earnings of $2.03 per share a year ago.

2 months ago · reuters.com

Steris beats quarterly estimates on continued demand for medical procedures

Medical equipment maker Steris beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales of its surgical and examination tools.

2 months ago · zacks.com

Steris (STE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Beyond analysts' top -and-bottom-line estimates for Steris (STE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e...

2 months ago · zacks.com

Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth

Steris (STE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago · zacks.com

STE Gears Up for Q2 Earnings: Here's What You Need to Know

STERIS' second-quarter fiscal 2025 results are likely to reflect the positives of normalizing the Healthcare backlog.